| Title | Principal Investigator | Sanctioned amount |
|---|---|---|
| Thrombin induces, in a concentration dependent, distinct population of extracellular vesicles from the endothelium: Its impact on homeostasis and cytoprotection | Dr. Kaushik Das | ₹ 83,16,000.00 |
| Study on the epigenetic mechanism of JAK-STAT driven plasticity in oral cancer stem cells for its therapeutic value | Dr. Sandeep Singh | ₹ 80,00,000.00 |
| Pylonephritics in Diabetics: Identifying underlying mechanisms influencing recurrent infection and establishing host mediated therapeutic approaches | Dr. Soumitra Mohanty | ₹ 76,50,000.00 |
| Investigating the Gut Microbiome and Host Epigenomic Profiles in Preterm Stunted Infants at 6 months of Age in a Low to Mid Socioeconomic Neighbourhood of North India | Dr. Souvik Mukherjee | ₹ 61,93,152.00 |
| Understanding The Molecular Mechanism In Ceramide Induced Pathological Activation Of Nek7/Nlrp3 – Inflammasome | Dr. P.B. Raghavendra | ₹ 54,03,560.00 |
| Investigating the role of PTPRM gene in lens thickness, identified from quantitative trait genome-wide association study | Dr. Moulinath Acharya | ₹ 50,68,840.00 |
| Influence of host genomic alteration on atopic dermatitis and involvement of gut-skin metagenomic axis | Dr. Souvik Mukherjee | ₹ 29,39,742.00 |
| Developing Research support services at National Institute of Biomedical Genomics | Dr. Alpana Dave | ₹ 9,99,720.00 |
| Title | Principal Investigator | Sanctioned amount |
|---|---|---|
| Whole Genome Sequencing of MTB Clinical Strains for Determining Drug Resistance and Strain lineage in India: A structured Nationwide approach | Prof. Arindam Maitra | ₹ 8,62,06,080.00 |
| MOMI: Biorepository Local Analysis India Phase II | Prof. Arindam Maitra | ₹ 8,37,09,225.00 |
| Identify, characterize and determine the in vivo efficacy of small molecules using a synthetic lethality screen which targets the major DNA repair pathways in colon and lung cancer | Dr. Sagar Sengupta | ₹ 83,48,692.00 |
| Proteomic profiling of extracellular vesicles (EVs) to identify markers that may facilitate specific isolation of tumor EVs from patient serum | Prof. Kartiki V. Desai | ₹ 53,98,230 |
| J.C. Bose Fellowship | Dr. Sagar Sengupta | ₹ 77,31,943.00 |
| Diabetes and Diabetic Retinopathy Microbiome Study- India | Dr. Souvik Mukherjee | ₹ 52,00,000.00 |
| Elucidating the role of Systemic Immune Response in Metastasis using Single Cell RNA Sequencing: Relation with Circulating Tumour Cell Biology and Clinical Implications | Prof. Arindam Maitra | ₹ 34,23,600.00 |
| Validation of Circulating Tumour Cells (CTCs) based diagnostics in Prognosticating Oral Squamous Cell Carcinoma: An Approach to Personalized Cancer Management | Prof. Arindam Maitra | ₹ 32,08,203.00 |
| Fast detection of driver mutations and genes from cancer genomics data using an integrative machine learning-based approach | Dr. Nidhan K. Biswas | ₹ 27,73,944.00 |
| Determine the mechanism of the turnover of key mitochondrial helicase, RECQL4, inside the organelle | Dr. Sagar Sengupta | ₹ 25,00,200.00 |
| Title | Principal Investigator | Sanctioned amount |
|---|---|---|
| Genomic surveillance of SARS-CoV-2 in India: Indian SARS-CoV-2 Genomics Consortium (INSACOG)-Phase II | Prof. Arindam Maitra (Sentinel), Dr. Souvik Mukherjee (Sewage) | ₹ 1,30,82,400.00 |
| Evaluation of growth factors and stem cell combination, novel formulation synergize to accelerate wound healing in diabetic foot ulcer models | Dr. P.B. Raghavendra | ₹ 50,08,000.00 |
| Design and Synthesis of Novel Carboline-Nucleosides with Potential Viral RdRp Inhibitor Activity: Development of Broad-Spectrum Antivirals Against RNA Viruses | Dr. Anup Mazumder | ₹ 46,27,828.00 |
| Interaction of Jumonji domain containing 6 protein (JMJD6) and Y-box containing protein 1 (YBX1) and it’s impact on breast cancer progression | Prof. Kartiki V. Desai | ₹ 45,07,401.00 |
| Investigating the molecular mechanism of action of 8q24.21 region specific long noncoding RNAs CASC19, CCAT1 in Pancreatic ductal adenocarcinoma | Dr. Srikanta Goswami | ₹ 44,86,733.00 |
| Investigating role of malignancy specific genes OSBPL3 and DLGAP5 in development and progression of pancreatic ductal adenocarcinoma | Dr. Srikanta Goswami | ₹ 34,50,200.00 |
| Deciphering the role of epigenetic modification in antiviral immune response to develop novel drug target | Dr. Anup Mazumder | ₹ 26,66,500.00 |
